Synonyms: | |
Status: | Approved (1996) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 7WY7YBI87E |
InChI Key | OBKXEAXTFZPCHS-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C10H12O2 |
Molecular Weight | 164.2 |
AlogP | 2.09 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 37.3 |
Molecular species | ACID |
Aromatic Rings | 1.0 |
Heavy Atoms | 12.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase GSK family
|
- | - | - | - | 126 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
- | 64000 | - | 2800 | 40 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIa
|
- | - | - | 2800 | 40 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | 2800 | 40 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IV
|
- | - | - | 2800 | 40 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 62 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
HIV Infections | 2 | D015658 | ClinicalTrials |
Brain Neoplasms | 2 | D001932 | ClinicalTrials |
beta-Thalassemia | 2 | D017086 | ClinicalTrials |
Maple Syrup Urine Disease | 2 | D008375 | ClinicalTrials |
Tuberculosis, Pulmonary | 2 | D014397 | ClinicalTrials |
Neuroblastoma | 1 | D009447 | ClinicalTrials |
Myositis, Inclusion Body | 1 | D018979 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 41500 |
ChEMBL | CHEMBL1469 |
DrugBank | DB06819 |
DrugCentral | 24 |
EPA CompTox | DTXSID2037631 |
FDA SRS | 7WY7YBI87E |
Human Metabolome Database | HMDB0000543 |
Guide to Pharmacology | 8480 |
PDB | CLT |
SureChEMBL | SCHEMBL1716 |
ZINC | ZINC000000056568 |